EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells

Kathrin Hedegger, Theresa Hommel, Monika Schaubeck, Martina Gimpfl, Maik Dahlhoff

European Journal of Nutrition · 2025

DOI: 10.1007/s00394-024-03507-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nutrition, 2025. Verfasst von Kathrin Hedegger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU München, Feodor-Lynen-Straße 25, 81377, Munich, Germany. Hauptthemen laut MEDLINE: Interleukin-6, Infant Formula, Toll-Like Receptor 9, Intestinal Mucosa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Veterinary Medicine Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Necrotizing enterocolitis (NEC) is the most severe gastrointestinal disease in preterm infants caused by an exaggerated intestinal epithelial immune activation. Several studies show that modulation of toll-like receptor 9 (TLR9) activity may have positive effects on preventing intestinal inflammatory mechanisms ultimately resulting in NEC development. In this study, the effect of various infant formulas (IF) and the probiotic strain Limosilactobacillus fermentum CECT5716 on TLR9 activation were analyzed in vitro.

Methods

First, TLR4 and TLR9 expression was analyzed on human primary intestinal epithelial cells (P-IECs) by qPCR and Western blot analysis. Then genetically designed HEK-Dual™ hTLR9 (NF/IL8) reporter cells (HEK-Dual) were treated with different IFs, L. fermentum CECT5716, and different functional components to measure TLR9 activation via luminescence. Finally, the IFs were investigated in P-IECs to analyze TLR downstream signaling by Western blot analysis.

Results

IFs containing intact protein and L. fermentum CECT5716 activated TLR9 in HEK-Dual cells, but the functional components lactoferrin, L-5-methyltetrahydrofolate, and hydrolyzed whey proteins failed to activate TLR9. In P-IECs, the IFs induced increased phosphorylation of MAPK8/9 of the TLR signaling pathway and significantly reduced IL6 levels. Consistently, IL6 levels were increased in P-IECs when TLR9-signaling was inhibited. Interestingly, L. fermentum CECT5716 enhanced TLR9-signaling and increased NF-kappa-B inhibitor alpha-phosphorylation.

Conclusion

We found out that the used control formula, prebiotic formula, prebiotic formula with hydrolyzed-protein, and L. fermentum CECT5716 reduce IL6 levels in human P-IECs through TLR9 activation. L. fermentum CECT5716 and the here tested IFs could be a promising approach for modulation of gut health in infants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6Infant FormulaToll-Like Receptor 9Intestinal MucosaEpithelial CellsHumansLimosilactobacillus fermentumEnterocolitis, NecrotizingProbioticsInfant, NewbornInfantCells, CulturedSignal TransductionToll-Like Receptor 4

Stichwörter der Autor:innen

IL6Infant formulaIntestineNECTLR4TLR9

Substanzen

Interleukin-6Toll-Like Receptor 9TLR9 protein, humanToll-Like Receptor 4

Autor:innen und Institutionen

  • Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU München, Feodor-Lynen-Straße 25, 81377, Munich, Germany.
  • Institute of in vivo and in vitro Models, University of Veterinary Medicine Vienna, Veterinärplatz 1, 1210, Vienna, Austria.
  • HiPP GmbH & Co. Vertrieb KG, Georg-Hipp-Straße 7, 85276, Pfaffenhofen, Germany.
  • Institute of in vivo and in vitro Models, University of Veterinary Medicine Vienna, Veterinärplatz 1, 1210, Vienna, Austria. Maik.Dahlhoff@vetmeduni.ac.at.

Förderung

  • University of Veterinary Medicine Vienna

Zitieren

APA

Hedegger, K., Hommel, T., Schaubeck, M., Gimpfl, M., & Dahlhoff, M. (2025). Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells. European Journal of Nutrition. https://doi.org/10.1007/s00394-024-03507-7

Vancouver

Hedegger K, Hommel T, Schaubeck M, Gimpfl M, Dahlhoff M. Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells. European Journal of Nutrition. 2025. doi:10.1007/s00394-024-03507-7

BibTeX
@article{Hedegger2025,
  author = {Hedegger, Kathrin and Hommel, Theresa and Schaubeck, Monika and Gimpfl, Martina and Dahlhoff, Maik},
  title = {Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells},
  journal = {European Journal of Nutrition},
  year = {2025},
  doi = {10.1007/s00394-024-03507-7}
}
Kostenlos starten →